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INTRODUCTION
One of the features of cytotoxins (CTs, sometimes called 
cardiotoxins) from snake venom is their toxicity to cells of 
various types [1]. CTs are small basic proteins from the three-
finger toxin group. The secondary structure of CTs consists of 
two β-sheets that have 2 and 3 antiparallel β-strands and is 
stabilized with 4 disulphide bonds. The major differences be-
tween the amino acid sequence and the 3D structure of mem-
bers of this large CT group occur in irregular loop segments, 
primarily in loops I and II. Depending on the presence of the 
conservative residues S28 (S-type) or P30 (P-type) in loop II, 
CTs exhibit different functional activities [2]. For a long time, 
CTs were believed to interact with the cell membrane in a 
nonspecific way. P-type CTs interact with the bilayer more 
actively than S-type CTs due to the more hydrophobic loop 
II, resulting in an extended hydrophobic region on the toxin’s 
surface formed by the hydrophobic tips of the three loops. 
The amphiphilic properties of CT molecules (the hydrophobic 
ends of loops I–III are flanked with cationic residues) enable 
their embedding into the lipid bilayer, creating porous defects 
in the membrane [3–6] and leading to the cell death. Several 
models of the mechanism of bilayer damage by CT and lysis 
have been proposed [7]. It was shown later that some CTs, 
for instance the CT А3 (Naja atra), can penetrate inside the 
cell and interact with cell organelles, mitochondria [8], and 
lysosomes [9].
The biological activity of CTs is very diverse. In particu-
lar, they can modify the function of various membrane pro-
teins, such as protein kinase C (PKC), Na+, K+-ATPase, and 
integrins. Therefore, the hypotheses about the specific CT 
targets and molecular mechanisms of toxin-membrane in-
teraction are of interest and have been actively discussed [7, 
10–12].
Based on NMR and X-ray data, a search for potential CT 
targets revealed a series of anionic low molecular weight 
ligands (heparin-derived oligosaccharides, ATP derivatives, 
and sulphatide) that interact with certain sites on the toxin’s 
surface [13–17]. Fluorescent spectroscopy studies on lipo-
somes of various composition combined with in vivo experi-
ments using monoclonal antibodies indicate a specific CT 
target—a polar head of a glycolipid sulphatide (hSGC)—
located on the surface of a rat’s cardiomyocyte membrane, 
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which mediates the toxic activity of CT А3 [17]. Taking into 
account the fact that CTs affect various cell types and that 
toxins effectively lyse model membranes containing no gly-
colipids [5, 18, 19], one can expect CT to be able to interact 
nonspecifically with other anionic membrane lipids, includ-
ing the most common one, phosphatidylserine (PS). Al-
though this lipid is normally localized in the inner leaflet of 
the cell membrane, when the bilayer is damaged in certain 
pathologies, PS is present in the outer leaflet and can be ac-
cessible to CT molecules. Some experimental data indirectly 
support the possibility that there is competition for a site on 
the membrane’s surface between CT and other PS-binding 
molecules (PKC, thionin) [10, 20, 21].
In this work we assumed that PS is a specific target me-
diating CT cell toxicity and studied the interaction of S-type 
(CT I from Naja oxiana) and P-type (CT II from Naja oxiana 
and CT 4 from Naja kaouthia) cytotoxins with palmitoyl oleyl 
phosphatidylcholine (POPC) membranes, including those 
containing PS and SGC. It should be noted that the primary 
structure of CT 4 (N. kaouthia) is identical to that of CT А3 
(N. atra). Using fluorescent spectroscopy, we studied the lytic 
activity of the selected CTs on liposomes of various compo-
sition. In order to identify sites in a CT molecule capable of 
binding PS, we performed molecular docking simulations of 
the PS polar head using 3D models of toxins active with re-
spect to PS-containing liposomes. Based on the results ob-
tained, we hypothesized that toxins interact with the bilayer 
via a two-stage specific mechanism, the molecular determi-
nants of which are the polar heads of the anionic lipids, which 
interact with specific CT sites.
EXPERIMENT
Fluorescent Spectroscopy: CT Lytic Activity on PS-Contain-
ing Liposomes of Various Composition
CT I and CT II were extracted from N. oxiana venom fol-
lowing the technique described in [22]. CT 4 was extracted 
from N. kaouthia venom using the technique proposed in 
[23] and refined by reverse phase chromatography. The 
toxin’s structure was confirmed by mass-spectrometry us-
ing peptide mapping after the trypsin hydrolysis of the re-
duced pyridylethylated toxin derivative. Liposomes were 
prepared using SGC and PS extracted from bovine brain in 
the Laboratory of Lipid Chemistry, Institute of Bioorganic 
Chemistry, Russian Academy of Sciences (IBC RAS), and 
synthetic POPC (Avanti Polar Lipids, United States). Lipo-
somes of the following composition were prepared: POPC, 
POPC/PS5%, POPC/PS20%, POPC/PS35%, POPC/PS50%, 
POPC/PS70%, POPC/SGC5%, and POPC/SGC50%. Lipid 
solutions in chloroform/methanol (1:1) at appropriate con-
centrations were mixed, evaporated, and dried in vacuum. 
The lipid films were hydrated with a buffer containing 
50 mM tris-НСl (pH 7.8), 30 mM NaCl, 4 mM EDTA, and 
100 mM calcein. The suspension was incubated for several 
hours, subjected to 10 freeze/thaw cycles, and then forced 
through a 100-nm polycarbonate filter (NucleoPore, USA) 
20 times using a mini-extruder (Avanti Polar Lipids, United 
States). The external dye was eliminated by gel filtration 
using a Sepharose СL-4B column equilibrated with a buffer 
containing 50 mM tris-НСl (pH 7.8), 110 mM NaCl, and 4 mM 
EDTA. In addition, the activity of CT 4 with respect to SGC-
containing liposomes (POPC/SGC50%) was measured un-
der the conditions described in [6] (buffer: 10 mM tris-НСl 
(pH 7.4), 75 mM NaCl; 50 mM 6-carboxyfluorescein (6-CF) as 
fluorophore; lipid/protein ratio (L/P) ~62).
The level of liposome membrane damage by CTs was esti-
mated from spectrophotometric measurements of the amount 
of fluorophore released from inside the liposomes, I, upon 
adding an aliquot of the toxin solution into the quartz cuvette   
with the liposome sample. The value of I (%) was calculated 
using the following equation: 
I = 100 x (F – F0) / (Ft – F0),
where F0 is the fluorescent signal from liposomes without the 
toxin (background level); F is the fluorescent signal from li-
posomes in the presence of the toxin; and Ft is the fluorescent 
signal after the liposomes have been destroyed with a deter-
gent (Triton X-100).
The L/P ratio in all experiments was 100, unless otherwise 
stated. The fluorescent signal was measured at 517 nm, with 
excitation at 494 nm, and the spectral slit width for excitation 
and emission was 3 and 5 nm, respectively. For each experi-
ment, the kinetics of the fluorescent signal was monitored (for 
about 40 min) and the final measurements were taken when 
I reached a plateau. For reproducibility control, all measure-
ments were repeated 2–3 times. All measurements were per-
formed at room temperature using HITACHI F4000 (Japan) 
spectrofluorimeter.
Molecular Docking of PS Polar Head in CT II and CT 4
Molecular docking simulations using GOLD 2.0 software [24] 
were performed to identify PS binding sites on the surface of 
CT molecules.
In our simulations, we used a crystallographic model of 
the 3D structure of CT А3 from N. atra venom (PDB code: 
2BHI) [17] and NMR models of CT II in hydrated state (PDB 
code: 1CB9, models 1, 14 and 18) [25] and in the presence of 
dodecylphosphocholine (DPC) micelles (PDB code: 1FFJ, 
models: 1 and 10) [4].
In order to account for the receptor’s conformational mo-
bility, we used a series of 3D models representing the dy-
namic behavior of the toxins in media of different polarities. 
Starting from experimental toxin models, we obtained rep-
resentative sets of corresponding 3D models of CT 4 and CT 
II by molecular dynamics simulations in aqueous media and 
by Monte Carlo conformational search for finding low-ener-
gy states in the presence of the implicit membrane (data not 
published).
The phosphatidylserine polar head (hPS) used in the simu-
lations included all atoms of this lipid’s polar head group with 
СН3 groups, instead of fatty acid residues (Fig. 1a). hPS dock-
ing simulations were performed for 16 and 15 spatial models 
of CT 4 and CT II, respectively.
For each CT model, 50 complexes (docking solutions) were 
obtained, among which 10 with the best “gold score” crite-
rion [26] (TOP10) were used for further analysis. Thus, for 
CT 4 and CT II, 160 and 150 ТОР10 solutions in total were 
selected, respectively. We made decisions about hPS binding 
sites at CT by analyzing the localization of hPS on the toxins 90 | ACTA NATURAE |  VOL. 2  № 2 (5)  2010
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molecule’s surface and the frequency of occurrence of corre-
sponding complexes in the ТОР10 solutions. The hPS surface 
is polar; therefore, hydrogen bonds and electrostatic forces 
contribute most to the lipid-toxin complex energy. The dock-
ing solution sets were analyzed with respect to the number 
and distribution of hydrogen bonds and ionic contacts (those 
with distances between ionic groups below 6 Å) in order to 
identify the key residues involved in the interaction with hPS 
in most of the complexes.
The presence of hydrogen bonds and ionic interactions was 
estimated using the PLATINUM [27] and GROMACS 3.3.1 
[28] software packages.
RESULTS
Fluorescence Measurements: CT-Induced Release of Dye 
from Liposomes 
Dependence of CT activity on a type of minor (5%) anionic 
lipid (PS, SGC). In this work, we estimated the lytic activ-
ity of P- and S-type toxins, namely CT II (N. oxiana), CT 4 
(N. kaouthia), and CT I (N. oxiana) by the amount of organic 
dye calcein released from POPC, POPC/PS5%, and POPC/
SGC5% liposomes. CT I (S-type) shows almost no activity 
with respect to both neutral liposomes (POPC) and those con-
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Fig. 1. (a) 3D model of the PS polar 
head (hPS) used in molecular dock-
ing simulations. Functional groups are 
indicated. (b–h): Molecular docking 
solutions for hPS bound in the M site 
of (b, d) CT 4 and (c) CT II, in the L3 
site of (e) CT II and (f) CT 4, and in the 
L1 site of (g) CT II and (h) CT 4. 3D 
models of the toxins are shown in a 
ribbon representation. The membrane 
binding hydrophobic residues of loops 
I–III (designated with roman numbers), 
backbone and/or side chain atoms 
of the site-forming residues, and one 
of the preferred conformations of hPS 
in the related sites are displayed as 
stick diagrams. To demonstrate the 
diversity of hPS positions in the sites, 
the corresponding locations of the hPS 
phosphate group are also shown in 
stick representation for other docking 
solutions from the TOP10 set. Amino 
acid residues forming the sites are 
marked with a one-letter code, with a 
residue number and a standard color-
ing scheme for the atom types. The 
phosphate group and carbon atoms of 
hPS are pink and cyan, respectively. 
(b) Different positions of hPS in the 
site M_Y51 of CT 4 found among the 
TOP10 docking solutions. A hypotheti-
cal migration path of hPS from the M_
Y51 site towards the M site is shown 
by arrows. The phospholipid bilayer is 
depicted as the shadow region under 
the horizontal line. The location of CT 
4 relative to the membrane’s interface 
(the horizontal line) corresponds to the 
proposed mode of CT binding to the 
lipid membrane.RESEARCH ARTICLES
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taining minor quantities of anionic lipids (PS, SGC) (Fig. 2): 
in all cases intensity of the released calcein, I, was below 5%. 
In experiments with CT II (Р-type), the release intensity of 
dye was higher (compared to the results obtained with CT I), 
average I values being below 10% regardless of the liposome 
composition (Fig. 2).
Fluorescence measurements showed that CT 4 had the 
strongest damaging effect on all the liposome types studied 
(Fig. 2). With this toxin, a clear trend is visible: its activity 
depends on the presence and type of the anionic component 
in the liposome. Thus, the value of I for neutral liposomes was 
only ~10%, whereas for SGC-containing vesicles it was 30%. 
The highest CT 4 activity was measured for POPC/PS5% li-
posomes, with dye release reaching 50%. It should be noted 
that there was also a significant difference in the activity of 
individual toxins with respect to the anionic lipids in lipo-
somes. For instance, CT II does not differentiate between PS- 
and SGC-containing liposomes, while the lytic activity of CT 
4 with respect to POPC/PS vesicles is almost twice as high as 
that with respect to SGC-containing ones (Figs. 2 b, d).
It is interesting that we did not find a specific interaction 
between SGC molecules and CT 4 (which is identical to CT 
А3 from N. atra venom). Moreover, when we reproduced the 
experimental conditions described in [6] (see the Experiment 
section), the value of I after a few minutes of incubation was 
less than 10%, unlike the >70% reported in [6] (Fig. 2 c). The 
authors of [6] used 6-CF fluorofore, which, due to its lower 
molecular charge, is prone to spontaneously releasing from 
liposomes (A.V. Feofanov, private communication).
CT-induced permeability of POPC liposomes with different 
PS content. We measured I for the interaction of CT I, CT II, 
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Fig. 2. CT-induced release of fluorescent dye calcein from liposomes of different compositions:  (a) pure POPC; (b) POPC/PS5%, 
and (d) POPC/SGC5% after addition of CT I, CT II (Naja oxiana), and CT 4 (Naja kaouthia). (c) Kinetics of 6-CF fluorescence during 
the initial few minutes after addition of CT II and CT 4. For this measurement, (c) the experimental conditions, such as buffer composi-
tion, fluorophore and lipid/protein concentrations (10/0.16 μM) in the sample correspond to those in [6]. The data for 6-CF release 
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and CT 4 with POPC liposomes containing varying amounts 
of PS (20, 35, 50, and 70%) and studied the dependence of the 
lytic efficiency on the anionic lipid concentration. The lat-
ter turned out to be similar for all three toxins; in particular, 
there was a maximum in I at 20% PS (Fig. 3) for all CTs. The 
toxicity trend CT 4 > CT II > CT I stays the same for all lipo-
some types at the given lipid/protein ratio (L/P = 100). The 
lytic effect of CT 4 and, especially, CT II increases drastically 
for liposomes POPC/PS20% (over 90 and 70%, respectively). 
At lower (5%) and higher (35% and more) PS contents, the 
drop in the activity curve I is more pronounced for CT II than 
for CT 4. CT I shows low lytic activity in the entire range 
of PS contents in the liposomes, with a weak maximum at 
PS20% (Fig. 3).
To explain the observed effects, we assumed a uniform 
distribution of PS in the liposomes and calculated the number 
of PS molecules per toxin molecule in liposomes of various 
composition that were 1000 Å in diameter. It appeared that 
the number of PS molecules for liposomes, with respect to 
which CTs show the maximum activity, is the same as the 
number of potential binding sites for the lipid head found in 
molecular docking simulations. In the case of complete toxin 
binding at L/P = 100, the liposome charge is compensated in 
the POPC/PS20% liposomes. Thus, there are 10–12 PS mol-
ecules (on average, 3.5 PS at the toxin’s binding site) per each 
toxin molecule. There are 50–60 lipids in total per each toxin, 
and 16–18 lipids are located in direct proximity to the contact 
region with toxin.
For comparison, in the POPC/PS5% liposomes, charge 
compensation occurs at very low CT concentrations (L/P 
~300); therefore, at a higher toxin content (L/P = 100), some 
CT molecules may not bind to the membrane. However, even 
if there is complete CT binding to the POPC/PS5% liposome 
surface, there may not be a single PS molecule at the toxin/
lipid contact region (on average, there are 0.8 PS molecules 
per surface area in contact with a toxin molecule).
 
Molecular Docking
As a result of molecular docking simulations of hPS into 3D 
models of CT 4 and CT II, three hPS binding sites (referred 
to further as М, L3, and L1) consisting mainly of conserva-
tive residues were found on the surfaces of both toxins. One 
feature of the complexes that were formed is the multivari-
ant positioning of the ligand in the sites (Fig. 1), which is due 
to the presence of several donor–acceptor groups capable of 
forming hydrogen bonds in both the ligand and the receptor.
The M site. The M site is the most frequently occurring one 
among the ТОР10 docking solutions; it is present in 75 and 
60% of solutions for CT 4 and CT II, respectively (Fig. 4). The 
site M includes a “lysine” cluster (K5, K12, K18, K35) sur-
rounding the polar surface (the site’s bed), which is formed 
by the backbone atoms of the residues L6, R36, G37, C38 and 
Y22 OH-group (Figs. 1c, 1d). In more than 60% of solutions for 
both toxins, there are three or more hydrogen bonds between 
key residues of the site М (K12, Y22, R36, and C38) and hPS 
and, usually, several ionic contacts.
The mobility of side chains of lysine residues makes site M 
compatible with different hPS conformations (Figs. 1c, 1d). 
This site is present in the ТОР10 docking solutions for most 
CT 4 and CT II models, including the toxin structures deter-
mined experimentally.
In contrast to CT II, in the ТОР10 set for CT 4, there is a 
group of solutions (further referred to as М_Y51) in which 
the Y51 residue’s hydroxyl group is involved in binding of the 
lipid head (Figs. 1b, 2d). In most М_Y51 solutions (10 out of 
16 complexes), the hPS tail is oriented towards the tip of loop 
III (Fig. 1b). In the other М_Y51 solutions, the hPS glycerine 
group is oriented towards loop I with fewer hydrogen bonds 
with the ligand. Therefore, in this group of solutions, the lig-
and’s position is intermediate between those in the M_Y51 
and М sites. In this case, Y22 is a key residue with which the 
ligand interacts (via the hydrogen bond) during the supposed 
migration from the М_Y51 to the М site (Fig. 1b).
The L3 and L1 sites. In addition to the major (in the number 
of solutions) site М, there are two sites in the ТОР10 set, L1 
%PS
I
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%
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Fig. 3. Dependence of the CT-induced calcein release, I (%), on 
the PS content (in %) in the POPC liposomes. The fluorescence 
measurements were performed 10 min after the addition of the 
toxins. The values of I are calculated (see the Experiment sec-
tion) and averaged for 2–3 measurements.
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Fig. 4. Distribution histogram of docking solutions for the hPS 
binding sites (М, М_Y51, L3, L1) in CT II (grey) and CT 4 (black) 
molecules. The best scoring solutions (TOP10) for both toxins 
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and L3, located on the concave side of the CT molecule sur-
face near loops I and III, respectively. The frequency at which 
these sites occur among the TOP10 docking solutions is dif-
ferent for CT II and CT 4 (Fig.  4).
The L3 site is formed by the bakbone atoms of the P43, 
Y51, C53, and S45 conservative residues, as well as by the 
side chain of the S45 residue. In most of the CT–hPS com-
plexes, P43 and Y51 carbonyl groups and the S45 ОН-group 
fix the position of the ligand’s NH3
+ group by forming a hy-
drogen bond (Figs. 1e, 1f). In some solutions, the hPS glycer-
ine residue is oriented towards the tips of loops I–III and the 
K44 and K50 side chains are near the hPS phosphate group 
(Fig. 1f).
The site L1 and CT 4/CT II represents a region with high 
electrostatic potential containing side chains of the N4/K4, 
K23, R36, R58/K58, and N60 residues, which form favorable 
electrostatic contacts with hPS. In most docking solutions ob-
tained for CT II and CT, the hPS NH3
+ group is located near 
the N60 residue, forming a hydrogen bond with the side chain 
carboxyl or carbonyl group (Figs. 1g, 1h). The hPS molecule 
accommodates various orientations with respect to the toxin 
molecule and suggested bilayer, including those correspond-
ing to the lipid position in the bilayer (Fig. 1g).
DISCUSSION
The functional activity of cytotoxins arises from their inter-
action with the cell membrane; however, the mechanism of 
this interaction at the molecular level is still unknown. The 
oligomerisation of CTs necessary for forming pores in the 
membrane [5, 6] takes place not in solution, but apparently 
in the vicinity of the membrane; the details of this process 
and the geometry of the supramolecular complex are unclear. 
Understanding the initial stages of the toxin-membrane in-
teraction is extremely important for understanding the entire 
mechanism of cytotoxic activity.
The data obtained in this study on the release of calcein 
from the POPC, POPC/PS5%, and POPC/SGC5% liposomes, 
depending on the CT type (Р- or S-), correlate with the hy-
pothesis that the properties of the membrane-binding motif 
(tips of loops I–III) influence the CT lytic activity with re-
spect to the cell membranes. P-type CTs are known to more 
actively interact with the bilayer [2, 29, 30]. Indeed, both of 
the Р-type CTs studied, CT II and CT 4, demonstrated more 
pronounced lipolytic behavior (on POPC/PS5% and POPC/
SGC5%) than CT I, for which intensity of the released dye did 
not exceed 5%. It has been suggested that, due to the pres-
ence of polar residues in loop II (S28 and D29 in CT I) of the 
S-type CTs, their interaction with the bilayer involves fewer 
residues, primarily those of loop I [2, 31]. For identical bilayer 
embedding geometry, the calculated free energy of binding 
is higher for CT I than for CT II [30].
The experiments also showed that all the toxins studied 
were most active with respect to PS-containing liposomal 
membranes, and that the dye-release dependencies on the 
PS content were of dome shape and with the highest lysis in-
tensity for the POPC/PS20% liposomes. An estimation of the 
number of PS molecules in 1000-Å diameter liposomes at L/P 
= 100 suggests that the lysis intensity peak can be reached 
when there are no less than three PS molecules on the sur-
face of the bilayer in contact with the toxin during embed-
ding. Under such conditions, the difference in the intensity of 
the released dye for CT 4 and the significantly less active CT 
II is minimal (90 and ~70%) compared to the case of liposomes 
with a PS content other than 20%. We can speculate that the 
optimum PS content for lysis that ensures the involvement 
of all three toxin sites is very important for the efficiency of 
toxin–membrane interaction. The weak response observed 
for the nearly inactive CT I is, perhaps, due to the fact that 
that this toxin does not embed deep enough into the bilayer 
and/or because of the different binding geometry involving 
only one or two loops, resulting in a lower availability of sites 
for binding with PS.
The drastic decrease of the POPC/PS5% lysis efficiency 
indicates that the mechanism that binds the highly basic tox-
in with the anionic membrane includes nonspecific electro-
static attraction. As a result, due to the low membrane charge 
density and too few PS molecules as potential ligands (less 
than one per toxin–membrane contact region), the CT does 
not embed into the bilayer efficiently.
The observed decrease in CT 4 and CT II activity with 
respect to liposomes with PS contents of 35% and higher is 
most likely caused by a change in the bilayer’s properties, in 
particular, by an increase in the lipid packing density near 
the interface. For instance, the formation of mini-clusters of 
PS molecules becomes more probable. According to the data 
of molecular dynamics simulations for bilayers containing 20 
and 50% PS, in the latter case there are twice as many hydro-
gen bonds between PS polar heads near the interface (data 
not published).
The estimated number of PS molecules in the POPC/
PS20% liposomes interacting with CTs is the same as the 
number of the toxin PS-binding sites predicted by molecular 
docking simulations. It should be also noted that the embed-
ding of the hydrophobic tips of loops I–III of the toxins stud-
ied into the lipid bilayer has been confirmed by NMR data on 
CT II [4] and CT А3 (N. atra) [6] in micelles.
The M site (residues K5, K12, K18, Y22, R36, and C38), 
presents in most docking solutions, is identical to the sul-
phatide-binding pocket located on the convex side of the 
toxin molecule [17]. Indeed, the results of a chemical modi-
fication of lysine and tyrosine residues suggest that the site’s 
key residues, such as Y22 and K12, significantly influence 
the functional activity of CTs [32, 33]. Judging by the number 
of intermolecular hydrogen bonds and ionic contacts in the 
docking solutions, the M site has the best potential for form-
ing a stable complex with the ligand. Formation of the CT A3-
SGC complex in of a membrane-mimicking environment [17] 
indicates that other anionic components in the membrane can 
bind to the M site. At the same time, the superimposition of 
CT docking models, according to the mode by which they are 
embedded into the bilayer, indicates different availabilities 
of the sites for the PS head. For instance, the M site residues 
do not directly interact with the bilayer. In order to reach the 
M site, the lipid molecule must overcome the energy barrier 
so that the acyl part of the lipid will penetrate the polar in-
terfacial zone.
It is interesting that, in the М_Y51 docking models for CT 
4, the lipid binding site assumes a hydrogen bond between 
the lipid NH3
+ group and ОН groups of both tyrosine residues, 
Y22 and Y51, the phosphate group being near the mem-94 | ACTA NATURAE |  VOL. 2  № 2 (5)  2010
RESEARCH ARTICLES
brane’s surface. Therefore, we can expect that lipids reach 
the М_Y51 site faster than they reach the M site. Moreover, 
the existence of M_Y51 solutions differing in the involvement 
of the M site’s key residues and the orientation of the lipid’s 
glycerin residue can indicate a possible migration path of the 
lipid head from the М_Y51 site to the M site.
There is no direct experimental evidence of the existence 
of the L3 and L1 sites revealed by docking simulations. On the 
other hand, the L3 site located near loop III has a structure 
similar to that of the M site: the backbone atoms of this site’s 
residues (P43, Y51, and C53) form hydrogen bonds with the 
lipid’s polar head, which is additionally supported by an elec-
trostatic interaction with the ionic groups of lysine residues 
(K44 and K50). Recently, a consensus sequence L/PKSSLL 
based on a peptide sequence alignment (related to antibodies 
neutralizing N. atra venom) revealed by phage display has 
been proposed as an epitope involved in the action of CT A3 
from N. atra venom [34]. This epitope corresponds to a frag-
ment of the loop III sequence and contains the L3 site resi-
dues (P43–S45). The L3 site is the least available for PS in the 
bilayer, taking into account the CT-membrane binding mode. 
It is possible that, during later stages of embedding, when 
CT penetrates deeper and this site becomes more available, 
binding an additional lipid strengthens the CT-membrane 
interaction.
In contrast, among docking solutions for the L1 site (a polar 
cluster comprised mainly of charged residues at the base of 
loops I and II) there are models of complexes with hPS in the 
membrane–water interfacial zone (in case CT loops embed 
into the membrane). This indicates the availability of this site 
for the bilayer hPS. There have been reports of NMR studies 
showing that some L1 site residues take part in dATP bind-
ing [16].
It is interesting to note that just five amino acid substi-
tutions turn CT II into the much more lytically active CT 
4 (Fig. 5); the total charge of the molecule (+9) is the same 
for both CTs. It is not surprising therefore that, along with a 
high sequence homology and similar 3D structure, the dock-
ing results for the two CTs are also very similar, differing 
only in the frequency at which the sites occur among the 
docking solutions. Four out of five amino acid substitutions 
are localized near the L1 site (more frequently in the case of 
CT II), and three of them—in the areas most important for 
the toxin—are in loops I and II. Thus, the positive charge in 
CT II (K4/N4 in CT II/CT 4) is transferred to loop II (H31/
K31 in CT II/CT 4) in CT 4. On the one hand, this disturbs 
loops:
sec.structure:
СT I  Naja oxiana
СT II  Naja oxina
СT А3  Naja atra
СT 4  Naja kaouthia
Fig. 5. Sequence alignment for CT I, CT II, CT 4, and CT A3. The β-strands are indicated by b. Amino acid substitutions between CT 
A3 and CT 4 are underlined.
the hydrophobic pattern of loop II; on the other hand, lysine 
residues are known to anchor at the interface by interacting 
with the lipid phosphate groups [35], which may reduce the 
protein dissociation constant. A correlation has been found 
between the presence of a positive charge at the tip of loop 
II and CT hemolytic activity [36]. Although the K4/N4 and 
K58/R58 substitutions in toxins are localized relatively far 
from the membrane surface (assuming that the CT embeds 
with the tips of loops I–III), both residues are parts of the 
L1 site and form a hydrogen bond and/or ionic contact with 
the lipid’s serine head in the docking solutions. The S11/Y11 
substitution increases the hydrophobicity of the CT 4’s loop 
I by enabling the coupling of the F10 and Y11 aromatic resi-
dues, which can act as a good hydrophobic anchor. We can 
speculate that, due to the less favorable binding conditions in 
the M_Y51 site (manifested by the absence of this site among 
the ТОР10 solutions for CT II), the availability of the M site 
for the anionic lipid head is less for CT II. The local conforma-
tional differences between CT II and CT 4 can also contribute 
to the rearrangement of the hPS binding locations for the L1 
and L3 sites. At the same time, it is obvious that the simula-
tion data are not sufficient for a qualitative estimation of the 
possible changes of the lipid binding constants for the pre-
dicted sites and, therefore, for a detailed explanation of the 
differences in the CT II and CT 4 activities.
Also, we would like to note that our experiments on the 
release of calcein from the POPC/SGC5% liposomes and re-
producing the experimental conditions described in [6], where 
6-CF was used as fluorophore, did not reveal any high affin-
ity of CTs (in particular, CT 4) with respect to SGC, which 
was in disagreement with the data published in [6]. At the 
same time, the existence of the X-ray CT A3-SGC complex 
confirms that various anionic components in the membrane 
can bind to the M site, and experiments with SGC-specific 
antibodies and enzymes reveal a dependence between the CT 
A3 functional activity and the presence of SGC in the mem-
brane [17]. This glycolipid is present in low concentration in 
the outer membrane leaflet of rat cardiomyocytes, hence the 
big interest in SGC as a potential CT target. The low repro-
ducibility of the results achieved on model membranes, in ad-
dition to the importance of technical details (e.g., the nature of 
dye), emphasizes the need to exercise caution when extrapo-
lating to cells the results obtained using model systems. The 
functional activity of a toxin is likely to arise due to a number 
of factors that are not at all limited to the affinity to various 
membrane components.RESEARCH ARTICLES
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In conclusion, based on the data on fluorescence intensity 
of a due released from anionic liposomes with a varying con-
tent of an anionic lipid as a measure of CT 4, CT I, and CT II 
activity, as well as the results of molecular docking of hPS 
into CT 4 and CT II, our hypothesis is that there are specific 
lipid binding sites of various affinities on the toxin surface. 
The concept of a CT binding to the membrane surface in two 
stages (initially via electrostatic and then via hydrophobic in-
teraction), specific complexes of toxin with the anionic lipid’s 
polar heads being the determinants of the process, provides 
qualitative insight into the dependence that the fluorescent 
dye release has on the PS content in the POPC liposomes.  
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